在非传染性脑膜炎中使用免疫调节剂:光和影
Carolina Bernal-Morales1,2, Athimalaipet V Ramanan3, Carlos Pavesio4,5
1Moorfields Eye Hospital, NHS Foundation Trust, London, UK. carolbernalmo@gmail.com.
Eye (London, England)
|August 19, 2024
概括
非传染性脑膜炎 (NIU) 的治疗包括皮质类固醇,抗代谢物和生物药物,如TNF-α抑制剂. 本综述详细介绍了它们的使用,并强调了对比研究的必要性,以优化NIU管理.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非传染性脑膜炎 (NIU) 是全球视力丧失的主要原因.
- 皮质类固醇是急性NIU的标准,但有副作用限制长期使用.
- 非生物抗代谢物和生物TNF-α抑制剂是关键的类固醇节约剂.
研究的目的:
- 在NIU中提供对非生物和生物药物使用的全面概述.
- 通过总结当前的治疗选择,帮助临床医生在日常实践中.
- 确定目前NIU免疫调节疗法的知识缺口和弱点.
主要方法:
- 对NIU的非生物和生物治疗方法的现有文献的审查.
- 对抗代谢剂的疗效分析 (甲基酸盐,甲酸莫菲蒂尔,阿扎西奥普林).
- 评估TNF-α抑制剂作为耐火NIU的替代品.
主要成果:
- 抗代谢物是有效的,甲甲酸和mycophenolate mofetil往往比阿扎西奥普林更受青.
- 生物TNF-α抑制剂越来越多地用于对抗代谢物无反应的患者.
- 有限的数据存在于不同NIU亚型和最佳药物组合的比较有效性.
结论:
- 目前NIU的治疗选择取决于患者的因素和医生的偏好.
- 进一步的研究,包括随机试验,对于理解和优化NIU治疗至关重要.
- 需要更多关于NIU中免疫调节剂的比较性能和组合策略的数据.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
103
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
103
01:29Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
01:29Drugs for Treatment of Ulcerative Colitis in IBD
131
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
131